
AIP accelerates the drafting and review process of marketing materials to support therapeutic commercialization, from brochures to advertisements and educational resources.
Vendor
Palantir
Company Website

Overview
AIP streamlines the process for teams generating therapeutic marketing materials and surfacing to the user discrepancies with compliance standards, such as FDA regulations and the PhRMA Code on Interactions, and provides suggestions for enhancements. Users can leverage AIP to extract and contextualize text, images, charts, and graphs across a variety of document types, from image-heavy advertisements to drug efficacy data in a Detail Aid.
Additionally, AIP supports compliant document generation, including generation of compliant marketing phrases or localization of existing materials for specific geographical and therapeutic requirements.
AIP's core focus on privacy and security underpins this workflow and enables strict enforcement of granular access controls with transparency and usability to build a collaborative and trusted ecosystem. AIP helps teams comply with various regulations and standards including GDPR, FISMA, HIPAA, and GxP.
Features
- Advanced AI-powered material review: Using Large Language vision models like GPT Vision, AIP automatically extracts comprehensive context from marketing and Prescriber Information documents, including images and charts, to facilitate thorough compliance checks.
- Centralized compliance rule repository: Users can create or import a centralized, versioned library of compliance rules to evaluate documents, encompassing industry regulations such as FDA regulations and the PhRMA Code on Interactions, as well as tailored guidelines for specific regions and therapies.
- Streamlined editing with automated suggestions: Leveraging a human-approved content ontology, AIP recommends content to brand marketers for reuse and provides rephrasing options, expediting the material generation process for new marketing documents and localization.